Agenus Inc
NASDAQ:AGEN
| Market Cap (Intraday) | 125.65M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 4.65 |
| 10-Day MA | $4.88 |
| 50-Day MA | $3.27 |
| 200-Day MA | $3.57 |
Agenus Inc Stock, NASDAQ:AGEN
3 Forbes Road, Lexington, Massachusetts 02421-7305
United States of America
Phone: +1.781.674.4400
Number of Employees: 316
Description
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.